To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Bessemer to exit three firms for $1.25bn
The New York-based venture firm will profit from sales of portfolio companies to GlaxoSmithKline, Sony and Apple.
